<table border="1" cellpadding="3" width="85%" xmlns="urn:hl7-org:v3" xmlns:voc="urn:hl7-org:v3/voc" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td>Concomitant Drug<content stylecode="bold"> </content>
</td>
<td>Effect onConcentration ofLamotrigine orConcomitant Drug<content stylecode="bold"></content>
</td>
<td>Clinical Comment<content stylecode="bold"> </content>
</td>
</tr>
<tr>
<td>Estrogen-containing oralcontraceptive preparations containing 30 mcg ethinylestradiol and 150 mcg levonorgestrel</td>
<td>↓ lamotrigine   <br/>↓ levonorgestrel</td>
<td>Decreased lamotrigine concentrationsapproximately 50%. Decrease in levonorgestrel component by 19%.</td>
</tr>
<tr>
<td>Carbamazepineand carbamazepine epoxide<content stylecode="bold"> </content>
</td>
<td>↓ lamotrigine  <br/>? carbamazepine epoxide</td>
<td>Addition of carbamazepine decreases lamotrigine concentration approximately 40%.May increase carbamazepine epoxide levels.</td>
</tr>
<tr>
<td>Lopinavir/ritonavir</td>
<td>↓ lamotrigine</td>
<td>Decreased lamotrigine concentrationapproximately 50%.</td>
</tr>
<tr>
<td>Atazanavir/ritonavir</td>
<td>↓ lamotrigine</td>
<td>Decreased lamotrigine AUCapproximately 32%.</td>
</tr>
<tr>
<td> </td>
<td> </td>
<td> </td>
</tr>
<tr>
<td>Phenobarbital/primidone<content stylecode="bold"></content>
</td>
<td>↓ lamotrigine<content stylecode="bold"></content>
</td>
<td>Decreased lamotrigine concentration approximately 40%.</td>
</tr>
<tr>
<td>Phenytoin<content stylecode="bold"></content>
</td>
<td>↓ lamotrigine<content stylecode="bold"></content>
</td>
<td>Decreased lamotrigine concentration approximately 40%.</td>
</tr>
<tr>
<td>Rifampin<content stylecode="bold"></content>
</td>
<td>↓ lamotrigine<content stylecode="bold"></content>
</td>
<td>Decreased lamotrigine AUC approximately 40%.</td>
</tr>
<tr>
<td>Valproate<content stylecode="bold"></content>
</td>
<td>↑ lamotrigine  <br/>? valproate<content stylecode="bold"> </content>
</td>
<td>Increased lamotrigine concentrations slightly more than 2-fold.There are conflicting study resultsregarding effect of lamotrigine onvalproate concentrations: 1) a mean 25% decrease in valproate concentrations in healthy volunteers, 2) no change invalproate concentrations in controlled clinical trials in patients with epilepsy.</td>
</tr>
</tbody>
</table>